HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
2,2,6,6-Tetramethylpiperidin-4-yl heptanoate
TMPH HCl · TMPH hydrochloride solid, (Product is pure based on CHN, NMR and MS results)

Identifikatoren & physikalische Daten
| CAS No. | 849461-91-2 |
|---|---|
| Summenformel | C16H32ClNO2 |
| Durchschnittliche Molmasse | 305,9 g/mol |
| Monoisotopische Masse | 305,21215694 g/mol |
| SMILES | CCCCCCC(=O)OC1CC(C)(C)NC(C)(C)C1.Cl |
| InChIKey | XIDDVJIJIFWGIX-UHFFFAOYSA-N |
| PubChem CID | 16079014 |
| EC No. | 635-895-2 |
| DTXSID | DTXSID401017551 |
Chemische & physikalische Eigenschaften
| Polarare Oberfläche (TPSA) | 38,3 |
|---|---|
| H-Brücken-Donoren | 2 |
| H-Brücken-Akzeptoren | 3 |
| Frei drehbare Bindungen | 7 |
| Schwere Atome | 20 |
| Formalladung | 0 |
| Komplexität | 281 |
| Lagerbedingungen | 2-8°C |
| Löslichkeit | H2O: 22 mg/mL at ~60 °CH2O: 22mg/mL at~60°C |
| Aggregatzustand | solid |
| Farbe | white |
| InChI | 1S/C16H31NO2.ClH/c1-6-7-8-9-10-14(18)19-13-11-15(2,3)17-16(4,5)12-13/h13,17H,6-12H2,1-5H31H |
| InChIKey | XIDDVJIJIFWGIX-UHFFFAOYSA-N |
| SMILES | Cl.CCCCCCC(=O)OC1CC(C)(C)NC(C)(C)C1 |
Sicherheit & Vorschriften
| GHS-Einstufung | WarningH315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]P261, P264, P264+P265, P271, P272, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| Hazard Classes and Categories | Skin Irrit. 2 (100%) |
| Wassergefährdungsklasse (WGK) | 3 |
| R-Sätze (R) | 36/37/38-43 |
| Gefahrensymbole | Xi |
| Sicherheitshinweise (S) | 26-36/37 |
| Lagerklasse | 11 - Combustible Solids |
| Gefahrenklasse | Eye Irrit. 2Skin Irrit. 2Skin Sens. 1STOT SE 3 |
Anwendungen & Verwendung
Verwenden
TMPH Hydrochloride is a potent inhibitor of neuronal AChRs. Therapeutic agent potentially used for the treatment of this progressive neurodegenerative disease such as globoid cell leukodystrophy (GLD) or Krabbe disease.